Pacific Edge Signs on Provider Network Stratose | GenomeWeb

NEW YORK (GenomeWeb News) – Pacific Edge said on Thursday it signed an agreement with national provider network Stratose, further making Pacific Edge’s bladder cancer test available to more patients.

Stratose contracts with more than 850,000 direct and affiliate healthcare providers and offers a “medical network solution” to more than 8.6 million Americans, Pacific Edge said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.